On Sunday, the Food and Drug Administration authorized a third coronavirus vaccine, produced by Johnson & Johnson, for emergency use. This one’s a little different: It’s more shelf-stable than the mRNA vaccines already in distribution, and requires just one dose. Sounds great, right? Yet questions abound about the new vaccine—and the old ones, too.

Topics:  food   drug administration   jesse goodman—who   center   medical product access   safety   stewardship   georgetown university   fda   mother   jones   dr anthony fauci   jesse   goodman   j&j s   i ve   united states    i   pregnant   cdc   american college   obstetricians   gynecologists   the j&j   south africa   brazil   in   johnson    johnson   mj   moderna   jg   pfizer   rna   j&j   coronavirus   chief scientist   people   effective   studies   trials   dose   understand   variants   women   don   efficacy   effectiveness   spike   percent   variant   risk   place   immunity   data   shot   part   immune   protect   viruses   worry   strong   cells   health   dna   present   cell   adenovirus   system   tweak   emergency   severe   doses   response   transmission   community   year   advantage   limited   highly   public   threat   authorized   fat   evidence   body   produces   antibodies   levels   high   surface   emerge   events   kill   dramatic   feel   genetic   broader   naked   population   deaths   require   hospitalizations   real   long   urgency   protection   concern   head   sick   children   higher   frozen   regimen   job   prevent   reason   terms   study   respond   underway   
BING NEWS:
  • Takeaways from AP report on how the search for the coronavirus origins turned toxic
    The Chinese government froze meaningful efforts to trace the origins of the coronavirus pandemic, despite publicly declaring that it supported an open scientific inquiry, an Associated Press ...
    04/22/2024 - 6:06 am | View Link
  • FDA review confirms safety and efficacy of Pfizer coronavirus vaccine
    Warning: This graphic requires JavaScript. Please enable JavaScript for the best experience. Updated Dec. 8 at 1:30 p.m. Pfizer enrolled approximately 44,000 people ...
    12/8/2020 - 12:30 am | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Politics News